Furthermore, in a mouse model of human gastric cancer xenografts, administration of anti-NRP-1 mAb resulted in a marked reduction in both tumor volume and weight, without exhibiting any discernible toxic effects. This evidence concerns the gene NRP1 and gastric cancer.